MAY-20-13 Dr. Ronald Valdiserri writes to recognize the second anniversary of Combating the
Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care
& Treatment of Viral Hepatitis and to share
an important announcement from Dr. Howard Koh about plans to update and renew the
existing plan through
MAY-16-13 Dr. Howard Koh, the Assistant Secretary for Health, announced on May 16 that the partner agencies are committed and dedicated to renewing the Action Plan for another three years and are currently working on their vision and priorities for 2014-2016.
|FDA Antivirals Drugs Advisory Committee Meetings to Discuss the First Direct Acting Antivirals|
APR-26-11 On April 27 and 28, the FDA's Antiviral Drugs Advisory Committee will meet to discuss new drug applications for the first in class HCV protease inhibitors, Boceprevir (April 27) and Telaprevir (April 28).
Materials Now Available HereMaterials now available by clicking or following: http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AntiviralDrugsAdvisoryCommittee/ucm247236.htm